Institute of Orthopaedic Research and Biomechanics, Centre of Musculoskeletal Research, University of Ulm, Helmholtzstrasse 14, 89081 Ulm, Germany.
Biomaterials. 2010 Mar;31(8):2064-71. doi: 10.1016/j.biomaterials.2009.11.099. Epub 2009 Dec 11.
The combined use of nanoparticles and mesenchymal stem cells (MSC) in regenerative medicine requires the incorporation of the particles and, at the same time, undisturbed cell viability and maintenance of the multi-lineage potential of MSC. The aim of this study was to investigate the uptake of novel phosphonate-functionalised polystyrene nanoparticles prepared by miniemulsion polymerisation. After exposition of human MSC to the particles, their uptake and localisation were analysed by flow cytometry, confocal laser scanning microscopy (CLSM), and transmission electron microscopy (TEM). The osteogenic, adipogenic and chondrogenic differentiation potential was examined by analysing representative marker genes by RT-PCR. Flow cytometry revealed that after 5 and 16 days more than 98% of the MSC and of the cells, which underwent osteogenic and adipogenic differentiation were positive for particle association. CLSM and TEM demonstrated the successful intracellular incorporation of the particles without using any transfection agents and their presence over the cultivation period. The cell viability was found to be unaffected. Particle treated MSC maintained their potential for osteogenic, adipogenic and chondrogenic differentiation. It was concluded that the surface functionalisation with phosphonate groups provides a promising basis for the development of nanoparticles with high intracellular uptake rates for drug delivery or cell labelling.
纳米粒子与间充质干细胞(MSC)联合应用于再生医学需要将粒子掺入其中,同时保持细胞活力不受干扰,并维持 MSC 的多系分化潜能。本研究旨在研究通过细乳液聚合制备的新型膦酸酯功能化聚苯乙烯纳米粒子的摄取情况。在将人 MSC 暴露于粒子后,通过流式细胞术、共聚焦激光扫描显微镜(CLSM)和透射电子显微镜(TEM)分析其摄取和定位。通过 RT-PCR 分析代表性标记基因来检测成骨、成脂和成软骨分化潜能。流式细胞术显示,在 5 天和 16 天后,超过 98%的 MSC 和经历成骨和成脂分化的细胞对颗粒结合呈阳性。CLSM 和 TEM 证明了成功地在没有使用任何转染剂的情况下将颗粒掺入细胞内,并在培养期间存在。细胞活力未受影响。经粒子处理的 MSC 保持了其成骨、成脂和成软骨分化的潜能。研究结论认为,表面膦酸酯基团的功能化提供了一个有前途的基础,用于开发具有高细胞内摄取率的纳米粒子,用于药物输送或细胞标记。